BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NON‐BULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL

BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NON‐BULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL

Saved in:
Bibliographic Details
Published in:Hematological oncology Vol. 35; no. S2; pp. 81 - 82
Main Authors: Park, S.I., Olajide, O., Reddy, N.M., Budde, L.E., Ghosh, N., Richards, K.L., Deal, A.M., Noe, J.F., Shea, T.C., Ansell, S.M.
Format: Journal Article
Language:English
Published: Chichester Wiley Subscription Services, Inc 01-06-2017
Subjects:
Clinical trials
Consolidation
Hodgkin's lymphoma
Immunotherapy
Lymphoma
Monoclonal antibodies
Patients
Radiation
Targeted cancer therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2437_69